Enteral Nutrition Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Nasogastric, Nasoenteral, Sipping, and Others), Application (Gastrointestinal Disorders, Renal Di

The Enteral Nutrition market was valued at US$ 10.58 billion in 2024 and is projected to reach US$ 17.33 billion by 2031; it is expected to register a CAGR of 7.3% during 2025–2031. Increasing prevalence of gastrointestinal diseases and the rising cases of malnutrition and premature births are contributing to the growing enteral nutrition market size. However, the complications associated with the feeding systems hampers the enteral nutrition market growth. Further, development of plant-based nutrition products is expected to bring in new enteral nutrition market trends in the coming years.

Asia-Pacific region to witness fastest growth rate in the global enteral nutrition market. The Asia Pacific enteral nutrition market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the market is driven by rising prevalence of chronic diseases and the growing presence of market players across the region, conferring the highest manufacturing of enteral nutrition products. Furthermore, supportive government initiatives and research in the field of nutrition boost market growth. Countries such as Australia, India, and South Korea are estimated to witness various growth opportunities due to the rising development in the healthcare sector. In addition, governments of these countries are increasing their efforts to provide enteral and parenteral nutrition.

In terms of revenue, China dominated the Asia Pacific market in 2024. It is expected to continue its dominance in the global market during the forecast period.

China has experienced a significant rise in the elderly population. Its rapidly aging demographic has led to an increased prevalence of chronic diseases, necessitating nutritional support. According to the 2020 census data, ~264 million were in the age group of 60 and above, and accounted for almost 19% of the Chinese population. The China National Committee on Aging (CNCA) projected that the geriatric population is expected to reach ~487 million by 2050. The increasing prevalence of neurological diseases with the growing elderly population fuels the adoption of enteral nutrition in China. Stroke is the primary cause of death among older people across the country. According to the study published in Elsevier, 17.8 million cases of stroke, 3.4 million new strokes, and 2.3 million stroke-related deaths were reported in the country in 2020. Stroke is the most common cause of acute dysphagia, which may cause malnutrition and impact the quality of life of patients. Tube feeding of critically ill stroke patients is implemented as a nutrition improvement strategy in China.

The increasing number of cancer cases in China also benefits the enteral nutrition market. According to the WHO, ~4.8 million new cancer cases and ~2.5 million deaths due to cancer were reported in China in 2022. Every minute, nearly seven individuals are diagnosed with cancer, and four succumb to the disease. The use of enteral feeding is common in cancer patients undergoing chemotherapy, who often experience difficulty eating due to nausea, mouth sores, or gastrointestinal disturbances..

Enteral Nutrition Market Report Segmentation Analysis

Key segments that contributed to the derivation of the enteral nutrition market analysis are product type, application, age group, and distribution channel.

Based on product type, the enteral nutrition market is categorized into nasogastric, nasoenteral, sipping, and other. The nasogastric segment held the largest share in the enteral nutrition market in 2024.
In terms of application, the enteral nutrition market is segmented into gastrointestinal disorders, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest share in the enteral nutrition market in 2024.
By age group, the enteral nutrition market is bifurcated into adult and pediatric. The adult segment held the largest share in the enteral nutrition market in 2024.
Based on distribution channel, the enteral nutrition market is segmented into hospital pharmacies, retail stores, and e-commerce. The hospital pharmacies segment held the largest share in the enteral nutrition market in 2024

Enteral Nutrition Market: Competitive Landscape and Key Developments

Nestlé, Danone S.A., Abbott Laboratories, FrieslandCampina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schär AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms, Nutritional Medicinals, LLC are among the key companies operating in the enteral nutrition market.

The National Health Service (NHS), British Association for Parenteral and Enteral Nutrition, World Health Organization, US Department of Health and Human Services, Centers for Disease Control and Prevention, British Dietic Association, and National Safety Council are among the primary and secondary sources referred to while preparing the Enteral Nutrition market report.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the enteral nutrition market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the enteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving themarket, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.